Study of Antiepileptic Drug Effects on Child Development
NCT00353886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81
Last updated 2007-07-23
Summary
The specific aim of this study is to determine if in utero exposure produces differential antiepileptic drug (AED) effects on subsequent cognitive abilities and behavioral abnormalities in children
Conditions
Interventions
- PROCEDURE
-
TONI-3
- PROCEDURE
-
WRAT-3
- PROCEDURE
-
Connor's Rating Scales PRS & TRS
- PROCEDURE
-
Peabody Picture Vocabulary Test
- PROCEDURE
-
Children's Memory Scale
- PROCEDURE
-
WISC-3
- PROCEDURE
-
Behavioral Assessment System for Children PRS & TRS
Sponsors & Collaborators
- collaborator INDUSTRY
-
Augusta University
lead OTHER
Principal Investigators
-
Gregory Lee, Ph.D. · Augusta University
-
Kimford J. Meador, MD · University of Florida
Eligibility
- Min Age
- 6 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-09-30
- Completion
- 2007-06-30
Countries
- United States
- United Kingdom
Study Locations
More Related Trials
-
A Study of Divalproex Sodium in Children With ASD and Epileptiform EEG
NCT01170325 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)
NCT04873869 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
NCT06660394 ·Status: RECRUITING ·Phase: PHASE3
-
A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy
NCT05407727 ·Status: COMPLETED
-
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
NCT06908226 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
NCT05697614 ·Status: UNKNOWN ·Phase: PHASE4
-
Neurodevelopmental Effects of Antiseizure Medications (NEAM) - UG3 Phase
NCT05364853 ·Status: WITHDRAWN ·Phase: NA
-
Rolandic Epilepsy Genomewide Association International Study
NCT03547050 ·Status: COMPLETED
-
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
NCT06719141 ·Status: RECRUITING ·Phase: PHASE3
-
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
NCT00088452 ·Status: COMPLETED ·Phase: PHASE3
-
Physiologic Effects of Topiramate on Cognition
NCT02884050 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
NCT00228969 ·Status: COMPLETED ·Phase: PHASE2
-
Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies
NCT03166215 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetics of Anti-epileptic Drugs in Obese Children
NCT02993861 ·Status: COMPLETED
-
Valproate Response in Aggressive Autistic Adolescents
NCT00065884 ·Status: UNKNOWN ·Phase: PHASE3
-
Pediatric Epilepsy Study
NCT00050934 ·Status: COMPLETED ·Phase: PHASE3
-
Getting SMART for Pediatric Epilepsy
NCT05439876 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical-genetic Investigations in Children With Early Infantile Epilepsies
NCT01357707 ·Status: COMPLETED
-
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
NCT05067634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
NCT00004817 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
NCT02535091 ·Status: COMPLETED ·Phase: PHASE3
-
Pediatric Epilepsy Study
NCT00050947 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
NCT03059381 ·Status: COMPLETED
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Prediction of Childhood Epilepsy Outcome in Bangladesh
NCT00381537 ·Status: COMPLETED ·Phase: NA